Aethlon Medical Inc.

NASDAQ: AEMD · Real-Time Price · USD
1.15
-0.02 (-1.71%)
At close: Aug 15, 2025, 3:59 PM
1.16
1.31%
After-hours: Aug 15, 2025, 07:12 PM EDT

Aethlon Medical Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
-1.76B -6.25M -1.75M -2.81M -2.57M -2.43M -3.47M -3.03M -3.28M -2.47M -2.85M -3.81M -2.91M -3.79M -2.53M -2.01M -2.1M -2.26M -2.44M -1.77M -1.41M
Depreciation & Amortization
82.64M 83.86K 83.81K 85.83K 86.06K 85.83K 91.47K 91.43K 90.33K 79.54K 78.13K 52.57K 30.65K 25.32K 17.67K 69.02K 11.67K 11.16K 10.73K 9.27K 8.77K
Stock-Based Compensation
72.44M 72.44K 89.97K 113.49K 139.33K 139.12K 572.96K 257.18K 250.11K 260.31K 262.61K 313.54K 215.44K 228.39K 201.02K 201.06K 120.15K 150.21K 377.96K 167.04K 84.21K
Other Working Capital
n/a -507.13K -103K 481.23K 275.96K -402.04K 447.05K 153.47K 123.5K -435.9K 122.66K 204.85K 220.49K -132.69K -368.66K 16.44K 98.02K 114.85K -507.02K 200.29K 289.53K
Other Non-Cash Items
-108.16M 4.68M 70.68K 140.28K -1.22K 16.65K 2.71K 686.00 1.24K 1.02K 13.75K 143.95K 7.8K 20.82K 11.9K -1.11K -1.07K -768 -767 -768 -188
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -258.39K -500.46K 252.82K 599.73K -381.63K 421.15K -18.98K 458.12K -820.66K 542.08K 420.64K -76.72K 412.1K -420.76K -138.3K -104.14K -134.67K -140.94K 368.92K 216.38K
Operating Cash Flow
-1.71B -1.67M -2.01M -2.21M -1.75M -2.57M -2.38M -2.7M -2.48M -2.95M -1.95M -2.88M -2.73M -3.1M -2.72M -1.88M -2.07M -2.24M -2.2M -1.23M -1.1M
Capital Expenditures
n/a 2.19K -2.19K n/a -3 -4.91K -8.81K -6.77K -230.38K -11.29K -151.49K -739.16K -41.17K -212.4K -57.93K -40.49K -38.37K -5.25K -31.49K -5.33K -17.81K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a 2.19K -2.19K n/a n/a -4.91K -8.81K -6.77K -230.38K -11.29K -151.49K -739.16K -41.17K -212.4K -57.93K -40.49K -38.37K -5.25K -31.49K -5.33K -17.81K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -7.07K -3.83K n/a n/a n/a -9.84K n/a n/a n/a n/a n/a n/a -13.56K -28.13K n/a n/a -66.01K -16.13K n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-5.36M 4.2M n/a n/a -5.08K -7.19K -9.37K n/a -8.37K -2.64K -1.88K -7.97K n/a -10.64K -13.56K -28.13K -35.79K -26.14K -66.01K -16.13K -24.25K
Financial Cash Flow
-5.36M 2.36M -7.07K -3.83K 5.38M 42.57K 177.13K -9.84K 1.08M -2.64K -1.88K 8.3M 619.44K -10.64K -13.56K -28.13K 17.42M -26.14K -66.01K -16.13K 7.24M
Net Cash Flow
-1.74B 686.18K -2.03M -2.21M 3.63M -2.53M -2.2M -2.72M -1.64M -2.97M -2.1M 4.68M -2.15M -3.32M -2.74M -1.95M 15.31M -2.27M -2.29M -1.25M 6.12M
Free Cash Flow
-1.71B -1.67M -2.01M -2.21M -1.75M -2.57M -2.39M -2.71M -2.71M -2.96M -2.1M -3.62M -2.77M -3.31M -2.78M -1.92M -2.11M -2.24M -2.23M -1.23M -1.12M